265 related articles for article (PubMed ID: 36131071)
1. The role of LncRNA LBX2-AS1 in cancers: functions, mechanisms and potential clinical utility.
Su Y; Li C; Fang Y; Gu X; Zheng Q; Lu J; Li L
Clin Transl Oncol; 2023 Feb; 25(2):293-305. PubMed ID: 36131071
[TBL] [Abstract][Full Text] [Related]
2. LncRNA LBX2-AS1 promotes proliferation and migratory capacity of clear cell renal cell carcinoma through mitophagy.
Wang B; Wei Y; Han T; Ji P; Miao H; Wu X; Qian J; Shao P
Eur J Med Res; 2024 Feb; 29(1):103. PubMed ID: 38326905
[TBL] [Abstract][Full Text] [Related]
3. Novel long non-coding RNA LBX2-AS1 indicates poor prognosis and promotes cell proliferation and metastasis through Notch signaling in non-small cell lung cancer.
Tang LX; Su SF; Wan Q; He P; Xhang Y; Cheng XM
Eur Rev Med Pharmacol Sci; 2019 Sep; 23(17):7419-7429. PubMed ID: 31539129
[TBL] [Abstract][Full Text] [Related]
4. LncRNA LBX2-AS1 facilitates abdominal aortic aneurysm through miR-4685-5p/LBX2 feedback loop.
Li H; Zhang H; Wang G; Chen Z; Pan Y
Biomed Pharmacother; 2020 Sep; 129():109904. PubMed ID: 32559617
[TBL] [Abstract][Full Text] [Related]
5. LBX2-AS1 is activated by ZEB1 and promotes the development of esophageal squamous cell carcinoma by interacting with HNRNPC to enhance the stability of ZEB1 and ZEB2 mRNAs.
Zhang Y; Chen W; Pan T; Wang H; Zhang Y; Li C
Biochem Biophys Res Commun; 2019 Apr; 511(3):566-572. PubMed ID: 30824187
[TBL] [Abstract][Full Text] [Related]
6. LBX2-AS1/miR-219a-2-3p/FUS/LBX2 positive feedback loop contributes to the proliferation of gastric cancer.
Yang Z; Dong X; Pu M; Yang H; Chang W; Ji F; Liu T; Wei C; Zhang X; Qiu X
Gastric Cancer; 2020 May; 23(3):449-463. PubMed ID: 31673844
[TBL] [Abstract][Full Text] [Related]
7. Silencing of lncRNA LBX2-AS1 suppresses glioma cell proliferation and metastasis through the Akt/GSK3β pathway in vitro.
Wen H; Li Z; Song S; Xu L; Tong X; Yan H
Acta Biochim Biophys Sin (Shanghai); 2021 Mar; 53(4):446-453. PubMed ID: 33637977
[TBL] [Abstract][Full Text] [Related]
8. Long non-coding RNA LBX2-AS1 predicts poor survival of colon cancer patients and promotes its progression via regulating miR-627-5p/RAC1/PI3K/AKT pathway.
Fang J; Yang J; Chen H; Sun W; Xiang L; Feng J
Hum Cell; 2022 Sep; 35(5):1521-1534. PubMed ID: 35816228
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of Long Noncoding RNA LBX2-AS1 Promotes the Proliferation of Colorectal Cancer.
Li Q; Xie H; Jin Z; Huang J; Wang S; Zhang Z
Technol Cancer Res Treat; 2021; 20():1533033821997829. PubMed ID: 33733923
[TBL] [Abstract][Full Text] [Related]
10. The role of long non-coding RNA AFAP1-AS1 in human malignant tumors.
Ji D; Zhong X; Jiang X; Leng K; Xu Y; Li Z; Huang L; Li J; Cui Y
Pathol Res Pract; 2018 Oct; 214(10):1524-1531. PubMed ID: 30173945
[TBL] [Abstract][Full Text] [Related]
11. LBX2-AS1 promotes ovarian cancer progression by facilitating E2F2 gene expression via miR-455-5p and miR-491-5p sponging.
Cao J; Wang H; Liu G; Tang R; Ding Y; Xu P; Wang H; Miao J; Gu X; Han S
J Cell Mol Med; 2021 Jan; 25(2):1178-1189. PubMed ID: 33342041
[TBL] [Abstract][Full Text] [Related]
12. LncRNA MNX1-AS1: A novel oncogenic propellant in cancers.
Li T; Zhou S; Yang Y; Xu Y; Gong X; Cheng Y; Wang Y
Biomed Pharmacother; 2022 May; 149():112801. PubMed ID: 35290890
[TBL] [Abstract][Full Text] [Related]
13. DARS-AS1: A Vital Oncogenic LncRNA Regulator with Potential for Cancer Prognosis and Therapy.
Shu J; Xia K; Luo H; Wang Y
Int J Med Sci; 2024; 21(3):571-582. PubMed ID: 38322590
[TBL] [Abstract][Full Text] [Related]
14. Long noncoding RNA LBX2-AS1 promotes colorectal cancer progression via binding with PTBP1 and stabilizing KAT2A expression.
Zhao A; Wang Y; Lin F; Bai K; Gu C
J Biochem Mol Toxicol; 2022 May; 36(5):e23020. PubMed ID: 35253306
[TBL] [Abstract][Full Text] [Related]
15. Deciphering the oncogenic landscape: Unveiling the molecular machinery and clinical significance of LncRNA TMPO-AS1 in human cancers.
Saraswat SK; Mahmood BS; Ajila F; Kareem DS; Alwan M; Athab ZH; Shaier JB; Hosseinifard SR
Pathol Res Pract; 2024 Mar; 255():155190. PubMed ID: 38330619
[TBL] [Abstract][Full Text] [Related]
16. Identification of novel key lncRNAs involved in periodontitis by weighted gene co-expression network analysis.
Jin SH; Zhou RH; Guan XY; Zhou JG; Liu JG
J Periodontal Res; 2020 Jan; 55(1):96-106. PubMed ID: 31512745
[TBL] [Abstract][Full Text] [Related]
17. DLX6-AS1 is a potential biomarker and therapeutic target in cancer initiation and progression.
Zheng Q; Gu X; Yang Q; Chu Q; Dai Y; Chen Z
Clin Chim Acta; 2021 Jun; 517():1-8. PubMed ID: 33607068
[TBL] [Abstract][Full Text] [Related]
18. CDKN2B-AS1 as a novel therapeutic target in cancer: Mechanism and clinical perspective.
Hjazi A; Ghaffar E; Asghar W; Alauldeen Khalaf H; Ikram Ullah M; Mireya Romero-Parra R; Hussien BM; Abdulally Abdulhussien Alazbjee A; Singh Bisht Y; Fakri Mustafa Y; Reza Hosseini-Fard S
Biochem Pharmacol; 2023 Jul; 213():115627. PubMed ID: 37257723
[TBL] [Abstract][Full Text] [Related]
19. Potential role of RAB6C-AS1 long noncoding RNA in different cancers.
Salavaty A; Motlagh FM; Barabadi M; Cheshomi H; Esmatabadi MJD; Shahmoradi M; Soleimanpour-Lichaei HR
J Cell Physiol; 2018 Jan; 234(1):891-903. PubMed ID: 30076712
[TBL] [Abstract][Full Text] [Related]
20. Functional Role of a Novel Long Noncoding RNA
Lin C; Zhang S; Wang Y; Wang Y; Nice E; Guo C; Zhang E; Yu L; Li M; Liu C; Hu L; Hao J; Qi W; Xu H
Clin Cancer Res; 2018 Jan; 24(2):486-498. PubMed ID: 29101304
[No Abstract] [Full Text] [Related]
[Next] [New Search]
